CD47 and melanoma: First, we used in-silico ATAC-Seq analysis of the skin cancer melanoma (SKCM) dataset (https://gdc.cancer.gov/about-data/publications/ATACseq-AWG) containing malignant tissues obtained from 13 melanoma subjects (11 samples were analyzed in duplicates) and a melanoma dataset (GSE134432) containing 9 genetically homogenous melanoma patient-derived cell lines to gain insights into the accessibility of the CD47 promoter region.